益佰制药：11月26日召开董事会会议

Group 1 - The core point of the article is that Yibai Pharmaceutical (SH 600594) held a temporary board meeting on November 26, 2025, to discuss the addition of members to its specialized committee [1] - For the year 2024, Yibai Pharmaceutical's revenue composition is as follows: 77.44% from pharmaceutical manufacturing, 21.46% from medical services, and 1.1% from other businesses [1] - As of the report date, Yibai Pharmaceutical has a market capitalization of 3.3 billion yuan [1]